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7 kb; 11 exons. 
Transcription 
2292 nucleotides mRNA. 
Protein 
Description 






LDB1 is a nuclear protein that contains an N-terminal 
dimerization domain and a C-terminal LIM interaction 
domain (LID). LDB1 binds to LIM-homeodomain 
(LIM-HD) and LIM-only (LMO) proteins. It acts as an 
adaptor protein that mediates interactions between 
different classes of transcription factors and their 
cofactors. LDB1 forms a complex with LKB1, LMO4, 
and GATA-6. The tumor suppressor LKB1 is mutated 
in Peutz-Jeghers syndrome and various sporadic 
cancers. A complex containing LDB1, LKB1, LMO4, 
and GATA-6 induces cyclin-dependent kinase inhibitor 
p21 expression. Targeted deletion of the Ldb1 gene in  
mice displays multiple developmental defects that 
reveal a requirement of Ldb1 gene during normal 
development. 
Implicated in 
Oral squamous cell carcinoma 
Oncogenesis 
LDB1 and LMO4 are frequently detected in less-
differentiated and metastasized squamous carcinoma, 
and overexpressed at the carcinoma invasive front. 
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